Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumithra Mandrekar

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|April 20, 2015
Radiotherapy for extensive stage small-cell lung cancerAaron Mansfield, Sumithra Mandrekar
Current Problems in Cancer|November 29, 2005
Optimal timing for QOL assessmentsKelli Burger, Sumithra Mandrekar
Current Problems in Cancer|November 29, 2005
Presenting longitudinal dataSumithra Mandrekar, Celia Kamath
Current Problems in Cancer|November 29, 2005
Future directions in QOL researchSumithra Mandrekar, Amylou Dueck
Chinese Clinical Oncology|September 27, 2015
Introduction to special issue on biomarker-based clinical trial designs in oncologyDaniel J Sargent, Sumithra Mandrekar, Axel Grothey
Statistics in Medicine|October 13, 2005
An adaptive dose-finding design incorporating both toxicity and efficacyWei Zhang, Daniel J Sargent, Sumithra Mandrekar
Plos One|September 2, 2021
phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpointsJun Yin, Yu Du, Rui Qin, et al.
Clinical Lung Cancer|July 6, 2011
Long-term safety and tolerability of sorafenib in patients with advanced non-small-cell lung cancer: a case-based reviewAlex A Adjei, George R Blumenschein, Sumithra Mandrekar, et al.
Clinical Trials (London, England)|September 4, 2016
Comparison of futility monitoring guidelines using completed phase III oncology trialsQiang Zhang, Boris Freidlin, Edward L Korn, et al.
Nutrition and Cancer|October 18, 2011
The purported effects of alcohol on appetite and weight in lung cancer patientsAminah Jatoi, Yingwei Qi, Jason A Wampfler, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|April 20, 2015
Radiotherapy for extensive stage small-cell lung cancerAaron Mansfield, Sumithra Mandrekar
Current Problems in Cancer|November 29, 2005
Optimal timing for QOL assessmentsKelli Burger, Sumithra Mandrekar
Current Problems in Cancer|November 29, 2005
Presenting longitudinal dataSumithra Mandrekar, Celia Kamath
Current Problems in Cancer|November 29, 2005
Future directions in QOL researchSumithra Mandrekar, Amylou Dueck
Chinese Clinical Oncology|September 27, 2015
Introduction to special issue on biomarker-based clinical trial designs in oncologyDaniel J Sargent, Sumithra Mandrekar, Axel Grothey
Statistics in Medicine|October 13, 2005
An adaptive dose-finding design incorporating both toxicity and efficacyWei Zhang, Daniel J Sargent, Sumithra Mandrekar
Plos One|September 2, 2021
phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpointsJun Yin, Yu Du, Rui Qin, et al.
Clinical Lung Cancer|July 6, 2011
Long-term safety and tolerability of sorafenib in patients with advanced non-small-cell lung cancer: a case-based reviewAlex A Adjei, George R Blumenschein, Sumithra Mandrekar, et al.
Clinical Trials (London, England)|September 4, 2016
Comparison of futility monitoring guidelines using completed phase III oncology trialsQiang Zhang, Boris Freidlin, Edward L Korn, et al.
Nutrition and Cancer|October 18, 2011
The purported effects of alcohol on appetite and weight in lung cancer patientsAminah Jatoi, Yingwei Qi, Jason A Wampfler, et al.
Pageof 4